Comprehensive coverage

Cancer cell survival

When the scientists inhibited the production of the nucleic acid purine in the cancerous tissue (right), more T cells of the immune system penetrated it during the immunotherapy phase, compared to tissue that had not been pretreated with purine inhibitors (left). Photo production: Dr. Raya Elam

Vulnerability is acquired

Weizmann Institute of Science scientists, in collaboration with researchers from the National Cancer Institute and Ben-Gurion University of the Negev, recently found a genetic signature that differentiates between tumors that may respond to immunotherapy and tumors that are resistant to this treatment method. Besides better diagnostic tools for predicting the response of patients to immunotherapy
Bacteria (in green) establish a home in cancer cells and settle comfortably in the cell nucleus area. Source: Weizmann Institute

Cell within a cell: the bacteria that live inside cancerous tumors

  • 2 תגובות
Dr. Itai Tirosh and Julie Lafi. The most common and violent brain cancer

Against four cells - why is there currently no effective drug for the treatment of glioblastoma brain cancer?

  • No comments
Skin cancer (melanoma). From Wikipedia

The chances of success of immunotherapy depend on the degree of heterogeneity of the cancer tumor

  • One response
Dr. Ayelet Erez. To turn to side ways. Source: Weizmann Institute magazine.

A new option for cancer detection: detection of disturbance in nitrogen metabolism

  • No comments
Science website logo
SEARCH